Co-Director of Cancer Genetics and Epigenetics, Professor of Oncology
Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
Dr. Azad is a Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center (SKCCC), where she serves as Co-Director of the Developmental Therapeutics Clinical Research Program and the Cancer Genetic and Epigenetic Core Research Program. After completing her fellowship in Medical Oncology at the National Cancer Institute, she joined the SKCCC faculty and has led multiple national and international clinical trials of novel drugs for cancer patients over her tenure. She has significant peer- reviewed funding focusing on novel therapeutics in gastrointestinal cancers, including leadership on multiple multi-institutional projects including the Epigenetics and Colon Cancer Stand Up 2 Cancer Dream Teams and the Breakthrough Cancer Foundation’s Targeting KRAS in Pancreatic Cancer Team. She has held multiple leadership positions in national and international organizations, including serving on the NCCN Colorectal Cancer Guidelines committee, the NCI Colon Cancer Task Force, Chair of the Cholangiocarcinoma Foundation Scientific Advisory Board, and a presidential appointment to the National Cancer Advisory Board. Dr. Azad’s laboratory work is dedicated to translational research in drug development that will form the foundation of future clinical trials. Her work investigates drugs that work through epigenetic and targeted mechanisms and the intersection of these agents with immunotherapy, as well as novel classes of agents.